Candida auris is a multidrug-resistant fungal pathogen that presents a serious threat to
global human health. Since the first reported case in 2009 in Japan, C. auris infections have …

Multidrug resistance (MDR) can be a serious complication for the treatment of cancer as well
as for microbial and parasitic infections. Dysregulated overexpression of several members of …

Candida auris exhibits resistance to multiple antifungal drug classes and sterilization
agents, posing threats to the immunocompromised worldwide. Among the four major …

In recent years, we are facing the challenge of drug resistance emergence in fungi. The
availability of limited antifungals and development of multi-drug resistance in fungal …

Abstract The World Health Organization (WHO) declared certain fungal pathogens as global
health threats for the next decade. Candida auris (C. auris) is a newly emerging skin-tropic …

Invasive candidiasis caused by the pathogenic Candida yeast species has resulted in
elevating global mortality. The pathogenicity of Candida spp. is not only originated from its …

Introduction Candida auris is a newly emerging pathogenic fungus of global concern and
has been defined by the World Health Organization (WHO) as a member of the critical group …

Candida auris emerged as a human fungal pathogen only during the past decade.
Remarkably, C. auris displays high degrees of genomic diversity and phenotypic plasticity …

In this study, we explored the sphingolipid (SL) landscape in Candida auris, which plays
pivotal roles in fungal biology and drug susceptibility. The composition of SLs exhibited …

Gene expression variation can provide an overview of the changes in regulatory networks
that underlie phenotypic diversity. Certain evolutionary trajectories such as polyploidization …